Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. - Wikidata - wikimedia - TriplyDB

Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.

Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.

http://www.wikidata.org/entity/Q42905411

about

Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.Imaging biomarkers in primary brain tumours.Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.¹⁸F-FLT and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors PET/CT in Oncology: Current Status and Perspectives.Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy Molecular imaging of gliomas with PET: opportunities and limitations.Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.Positron Emission Tomography (PET) in Oncology Tumor-associated macrophages in glioblastoma multiforme-a suitable target for somatostatin receptor-based imaging and therapy?Image-derived input function for brain PET studies: many challenges and few opportunities.Quantitative PET imaging of tryptophan accumulation in gliomas and remote cortex: correlation with tumor proliferative activity Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agents Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.Technical Issues of [(18)F]FET-PET Imaging for Radiation Therapy Planning in Malignant Glioma Patients - A Review.Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.(18)F-FDG PET-CT-Negative Recurrent High-Grade Anaplastic Astrocytoma Detected by (18)F-FDOPA PET-CT.18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab.Emerging techniques and technologies in brain tumor imaging Comparative study of (18)F-DOPA, (13)N-Ammonia and F18-FDG PET/CT in primary brain tumors.The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma.18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors.Automated synthesis of N-(2-[18 F]Fluoropropionyl)-l-glutamic acid as an amino acid tracer for tumor imaging on a modified [18 F]FDG synthesis module.IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas.Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.Correlation of MRI-derived apparent diffusion coefficients in newly diagnosed gliomas with [18F]-fluoro-L-dopa PET: what are we really measuring with minimum ADC?[PET-MR in patients with glioblastoma multiforme].18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study."The simplest explanation is usually the correct one" - Can Occam's razor be applied for diffuse astrocytoma and paradoxical amino acid metabolism?

P2860

Q30596682-7F6A7077-C911-416C-A4DE-C2ADDBAA5B59 Q30880129-892A5C4C-0B86-40A5-B4D5-54763C3D8D9B Q30907831-350A67E9-E796-4289-85BD-63C7AB2D1527 Q33560943-1B22127F-F49E-496B-B860-A82837CFE4A6 Q33665109-DBC8C599-5904-4D64-A2E8-7580116CEBAC Q33838502-27A94905-F429-48AC-B48A-DDB2D2B3DE8D Q33961188-3A07E2E3-67C0-4BEA-A15C-D77E35B69A38 Q34348544-0592A616-9889-4EDB-B754-DE484E9092F0 Q34774840-88A76FF8-F77D-4F28-B553-4B7ED5793DC6 Q35217230-CF8BBF60-249E-4C83-AEEF-B510D5B390E0 Q35524029-77898C8D-1938-406F-AEE5-E4661DEA79D5 Q36164975-D67FBD74-D0F8-4584-9E4C-6826BAEF4D91 Q36205180-04A628E8-60DD-4B60-8330-F5CC9AD819EC Q36218548-E0016E8F-AE18-491F-A110-29CB589DB0B2 Q37273065-AE99FBD4-D0B2-445E-84BE-1580139835B6 Q37580486-9572A510-0DB4-49DE-91BB-A16D9E529115 Q38051641-3FFA3F3A-9C13-4732-9E01-96159FA8621E Q38743138-5264C592-0DC5-4EBE-8211-14320D514BCC Q38815396-0E2837A1-1B6D-4964-84A6-B8C2CE5B7E88 Q39031636-89FCE82F-7C37-4C4C-9479-CCBD2B8B8481 Q39974654-017EB795-0E17-44D3-9DAA-163E7422E4E8 Q41877778-B9756EBB-C1AF-481F-BACD-0D4AC1937F11 Q41995781-00DD1245-4DC3-48C0-9A40-F3E15BBB8251 Q42710397-7F091471-95AE-44F7-87AB-5F74C9FDEC2C Q42734117-0BCDC95B-E20B-4296-9682-7AACCF0C3129 Q45212386-68F9B3A0-BAF6-40CF-B930-F87D6F0D8CBC Q45267961-5F7E858E-6506-4573-A744-41E2FBF58092 Q46366163-C6373143-2124-425E-BC06-8DF174CFCF33 Q47833074-A2860465-6406-4605-9507-259EA9D42D7D Q48043005-BF188FAD-5056-4736-A51D-E9594986C38D Q48129018-285CD0A2-051D-4D3C-8D51-C4E556A5345E Q48158155-916F3FB9-F385-4615-BCE7-A116A3057A7F Q48330252-4802187B-E072-464B-A40F-AEF54D532F1D Q48934675-810A3493-840F-42B4-B450-C7E02D56FB0E Q54135407-A6F74589-A507-4B8C-B33A-833B8BC098C1 Q55458363-8AA482DA-B56C-4C5B-8F98-EA6D031E8BBE

P2860

Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.

http://www.wikidata.org/entity/Q42905411

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Correlation of 6-18F-fluoro-L- ...... agnosed and recurrent gliomas.

@en

Correlation of 6-18F-fluoro-L- ...... agnosed and recurrent gliomas.

@nl

type

label

Correlation of 6-18F-fluoro-L- ...... agnosed and recurrent gliomas.

@en

Correlation of 6-18F-fluoro-L- ...... agnosed and recurrent gliomas.

@nl

prefLabel

Correlation of 6-18F-fluoro-L- ...... agnosed and recurrent gliomas.

@en

Correlation of 6-18F-fluoro-L- ...... agnosed and recurrent gliomas.

@nl

P1433

Q42905411-2B9D1ADA-E01D-4066-B6BF-449CAC97AC8B

P1476

Q42905411-C60D7173-CF2E-4811-A4C2-4E2A5578BA78

P2093

Q42905411-533F307E-A303-4C17-B11A-EF2D185F6331

Q42905411-5BFA4F74-FBCD-4960-9FAF-016704F8931B

Q42905411-60A840FE-99E2-4108-857A-38792581DB58

Q42905411-867F4998-3306-40AA-9D62-1227D062DAB0

Q42905411-8B04B2E5-0E70-40A0-84FE-A22D21FD85B5

Q42905411-8D5C0277-1879-4212-A6D7-BC8103DF5334

Q42905411-94EB2475-9076-462B-8C2D-1F8DCECF1E79

Q42905411-C0987C67-502C-4E94-B955-C48D7014C9DA

Q42905411-FA70FDB3-C095-4BE2-A1E1-099961CF93E9

P304

Q42905411-1579220F-BC30-47D0-BFD9-1F62C89336F7

P31

Q42905411-AEACF19E-5A39-4940-832C-21CAAD81D821

P356

Q42905411-32118B89-BD6B-4615-B397-1E5A684FA0C6

P407

Q42905411-4A42266A-4EFA-4480-BCD4-5E4E464EF2AC

P433

Q42905411-6AD250DF-9C7E-43DF-B0AE-19003B2443E6

P478

Q42905411-8B163904-72E6-4766-B454-11492E5C1072

P50

Q42905411-1317EE43-F867-4720-B606-D0B8DE7D2FC7

Q42905411-BABFF8F9-FF6C-4446-8C32-6585C24F2005

P577

Q42905411-4D2C4AB1-4557-46D2-A35E-E7771F390948

P5875

Q42905411-C091E7F7-4105-4D3B-8BB5-51F5B445F0BE

P698

Q42905411-E2FDED58-4244-4DCD-8E72-3293024EBF48

P356

JNUMED.110.078592

P1433

The Journal of Nuclear Medicine

P1476

Correlation of 6-18F-fluoro-L- ...... agnosed and recurrent gliomas.

@en

P2093

Albert Lai

http://www.w3.org/2001/XMLSchema#string

Barbara J Fueger

http://www.w3.org/2001/XMLSchema#string

Cheri L Geist

http://www.w3.org/2001/XMLSchema#string

Christiaan Schiepers

http://www.w3.org/2001/XMLSchema#string

Daniel H Silverman

http://www.w3.org/2001/XMLSchema#string

Johannes Czernin

http://www.w3.org/2001/XMLSchema#string

Michael E Phelps

http://www.w3.org/2001/XMLSchema#string

Timothy Cloughesy

http://www.w3.org/2001/XMLSchema#string

Wei Chen

http://www.w3.org/2001/XMLSchema#string

P304

1532-1538

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.110.078592

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Phioanh Nghiemphu

P577

2010-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46288340

http://www.w3.org/2001/XMLSchema#string

P698

20847166

http://www.w3.org/2001/XMLSchema#string